Samsung has announced that the sleep apnea feature in the Samsung Health app, designed for compatible Samsung Galaxy watches (like the Watch 6 we reviewed) and phones, has received De Novo authorization from the U.S. Food and Drug Administration (FDA) ) – which makes it The first sleep apnea feature of its kind to receive FDA authorizationFollowing approval from the Korean Ministry of Food and Drug Safety (MFDS) in October 2023.
The sleep apnea feature is aimed at users aged 22 and older who have not yet been diagnosed with sleep apnea. Detect signs of moderate to severe obstructive sleep apnea (OSA) during a two-night monitoring period. OSA is a common, chronic sleep disorder that often goes undiagnosed and untreated, causing interruptions in breathing during sleep, leading to poor sleep quality and daytime fatigue, while untreated sleep apnea increases the risk of cardiovascular disease.
To use the feature, users need to track their sleep for more than four hours on two separate occasions within ten days; approximately 25% of men and 10% of women in the United States suffer from OSA, and this feature is expected to help Proactively detects sleep apnea, allowing individuals to seek medical care and reduce the risk of health-related complications.
When can it be used?
The sleep apnea feature is part of Samsung’s commitment to providing Galaxy users with advanced sleep tools. The feature is expected to be available on the Galaxy Watch series in the US through the Samsung Health Monitor app in the third quarter.
Submitted under . Learn more about Galaxy Watch and Samsung.